Detection of Mixed Populations of Clarithromycin-Susceptible and -Resistant Mycobacterium abscessus Strains
- 20 April 2022
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 60 (4) , e0169421
Abstract
Clarithromycin resistance in Mycobacterium abscessus subsp. abscessus , massiliense , and bolletii occurs through induction of erm (41) or mutations in rrl (23S rRNA) genes. Phenotypic detection of clarithromycin resistance is hindered by the need for extended incubation as well as co-occurrence of mixed populations of M. abscessusKeywords
Funding Information
- HHS | NIH | NIH Clinical Center
This publication has 32 references indexed in Scilit:
- New Rapid Scheme for Distinguishing the Subspecies of the Mycobacterium abscessus Group and Identifying Mycobacterium massiliense Isolates with Inducible Clarithromycin ResistanceJournal of Clinical Microbiology, 2013
- Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm (41) and rrl SequencingAntimicrobial Agents and Chemotherapy, 2011
- Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patternsMicrobiology and Immunology, 2010
- Cohort Study of Molecular Identification and Typing of Mycobacterium abscessus, Mycobacterium massiliense , and Mycobacterium bolletiiJournal of Clinical Microbiology, 2009
- A Novel Gene,erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates ofMycobacterium abscessusbut Is Absent fromMycobacterium chelonaeAntimicrobial Agents and Chemotherapy, 2009
- Intrinsic Macrolide Resistance in Rapidly Growing MycobacteriaAntimicrobial Agents and Chemotherapy, 2006
- The Structural Basis of Macrolide–Ribosome Binding Assessed Using Mutagenesis of 23S rRNA Positions 2058 and 2059Journal of Molecular Biology, 2004
- Nontuberculous Mycobacteria: II: Nested-Cohort Study of Impact on Cystic Fibrosis Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1994
- Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsAntimicrobial Agents and Chemotherapy, 1992